Trials / Active Not Recruiting

Active Not RecruitingNCT04304768

Opioid, HIV and Immune System

Immune Dysfunction in HIV+ Opioid Users

Status: Active Not Recruiting
Phase: Phase 4
Study type: Interventional
Enrollment: 400 (estimated)

Sponsor: University of Miami · Academic / Other
Sex: All
Age: 18 Years – 60 Years
Healthy volunteers: Accepted

Summary

The purpose of this research is to evaluate blood samples from HIV infected and non-HIV infected people opioid and non opioid users to understand how opioid affect the immune responses (body defenses against infection) to the flu vaccine.

Conditions

Immune Defect

Interventions

Type	Name	Description
BIOLOGICAL	Fluzone Quadrivalent	0.5 ml prefilled syringe administrated intramuscularly

Timeline

Start date: 2020-11-18
Primary completion: 2027-01-31
Completion: 2027-12-31
First posted: 2020-03-11
Last updated: 2026-03-27

Locations

1 site across 1 country: United States

Regulatory

FDA-regulated drug study

Source: ClinicalTrials.gov record NCT04304768. Inclusion in this directory is not an endorsement.